In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K/A | 10-K/A |
Total revenues | 18.0 | 21.3 | 0.0 | 0.0 |
Revenue growth | -15.7% | | | |
Cost of goods sold | 144.2 | 159.7 | 0.0 | 0.0 |
Gross profit | -126.2 | -138.4 | 0.0 | 0.0 |
Gross margin | -702.2% | -648.5% | | |
Selling, general and administrative | 66.0 | 71.3 | | |
Research and development | 78.4 | 88.4 | | |
Other operating expenses | -250.8 | -191.2 | 93.9 | -14.8 |
EBITDA [+] | -12.6 | -100.2 | | |
EBITDA growth | -87.5% | 6.7% | -735.5% | |
EBITDA margin | -69.8% | -469.8% | | |
Depreciation and amortization | 7.2 | 6.6 | | |
EBITA | -19.8 | -106.9 | -93.9 | 14.8 |
EBITA margin | -110.1% | -500.9% | | |
Amortization of intangibles | 2.2 | 2.2 | | |
EBIT [+] | -22.0 | -109.1 | -93.9 | 14.8 |
EBIT growth | -79.8% | 16.1% | -735.5% | |
EBIT margin | -122.3% | -511.2% | | |
Non-recurring items [+] | 3.6 | | | |
Asset impairment | 3.6 | | | |
Interest income | | | 1.8 | 3.8 |
Interest income | | | 1.8 | 3.8 |
Other income (expense), net [+] | 39.8 | 9.0 | 43.1 | -12.0 |
Change in fair value of warrants | 42.1 | 13.5 | | |
Other non-operating income | 0.4 | 0.3 | | |
Other non-ooperating expenses | | -3.2 | | |
Other | 0.4 | -2.8 | | |
Pre-tax income | 14.2 | -100.1 | -49.1 | 6.5 |
Income taxes | 0.0 | 0.0 | 0.2 | 0.7 |
Tax rate | 0.1% | | | 10.2% |
Net income | 14.2 | -100.1 | 0.0 | 0.0 |
Net margin | 79.0% | -469.3% | | |
|
Basic EPS [+] | $0.10 | ($1.49) | $0.00 | $0.00 |
Growth | -106.8% | | | |
Diluted EPS [+] | $0.09 | ($1.49) | $0.00 | $0.00 |
Growth | -106.3% | | | |
|
Shares outstanding (basic) [+] | 139.9 | 67.1 | 25.1 | 25.5 |
Growth | 108.6% | 167.1% | -1.7% | |
Shares outstanding (diluted) [+] | 149.8 | 67.1 | 25.1 | 25.5 |
Growth | 123.4% | 167.1% | -1.7% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |